{"cord_uid": "x0wij3gt", "sourcedb": "PMC", "sourceid": "PMC4699375", "divid": "8", "text": "The human bronchial epithelial cell lines BEAS - 2B and HBEc14 - KT were obtained from John Minna ( University of Texas Southwestern Medical Center , Dallas , TX , USA ) . They were maintained in KERATINOCYTE - SFM medium ( Invitrogen Corporation , Carlsbad , CA , USA ) supplemented with human recombinant epidermal growth factor 1 - 53 ( EGF 1 - 53 ) and bovine pituitary extract ( BPE ) . Cells were plated into six - well culture plates at an initial seeding density of 5 \u00d7 10 4 cells per well . The plates were incubated in a humidified atmosphere of 5 % CO 2 in air at 37 \u00b0 C . Lipofectamine 2000 reagent was purchased from Invitrogen . The CellTiter - Glo Luminescent Cell Viability Assay kit was purchased from Promega . Polyclonal antibodies against PDK1 and phosphorylated PDK1 ( ser 241 ) were purchased from Cell Signaling . The polyclonal antibody against c - Jun was purchased from Santa Cruz Biotechnology , Inc . Polyclonal antibody against EP4 , a 16 , 16 - Dimethyl - PGE 2 ( dmPGE2 ) solution in methyl acetate and AH23848 , OSU - 03012 were purchased from Cayman Chemical Co .", "project": "cdlai_CORD-19", "denotations": [{"id": 1, "span": {"begin": 357, "end": 382}, "obj": "ne"}, {"id": 2, "span": {"begin": 384, "end": 388}, "obj": "ne"}]}